These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3680572)

  • 1. Effect of congestive heart failure on the pharmacokinetics of cibenzoline.
    Massarella JW; Silvestri T; DeGrazia F; Miwa B; Keefe D
    J Clin Pharmacol; 1987 Mar; 27(3):187-92. PubMed ID: 3680572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteers.
    Brazzell RK; Khoo KC; Szuna AJ; Sandor D; Aogaichi K; Wills RJ
    J Clin Pharmacol; 1985 Sep; 25(6):418-23. PubMed ID: 4056077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
    Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J
    J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renal impairment on the pharmacokinetics of cibenzoline.
    Massarella JW; Khoo KC; Aogaichi K; Di Persio D; Smith M; Kluger J; Chow MS
    Clin Pharmacol Ther; 1988 Mar; 43(3):317-23. PubMed ID: 3345622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cibenzoline after single and repetitive dosing in healthy volunteers.
    Massarella JW; Khoo KC; Szuna AJ; Sandor DA; Morganroth J; Aogaichi K
    J Clin Pharmacol; 1986 Feb; 26(2):125-30. PubMed ID: 3950056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of enalapril in congestive heart failure.
    Dickstein K
    Drugs; 1986; 32 Suppl 5():40-4. PubMed ID: 3032562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative and absolute bioavailability of cibenzoline capsules and tablets in healthy subjects.
    Massarella J; Silvestri T; Lin A
    J Pharm Sci; 1986 Sep; 75(9):894-6. PubMed ID: 3783460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics and dose proportionality of oral cibenzoline.
    Khoo KC; Szuna AJ; Colburn WA; Aogaichi K; Morganroth J; Brazzell RK
    J Clin Pharmacol; 1984 Jul; 24(7):283-8. PubMed ID: 6480874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.
    Khoo KC; Givens SV; Parsonnet M; Massarella JW
    J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and cibenzoline disposition.
    Brazzell RK; Rees MM; Khoo KC; Szuna AJ; Sandor D; Hannigan J
    Clin Pharmacol Ther; 1984 Nov; 36(5):613-9. PubMed ID: 6488682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and pharmacokinetics of omapatrilat in heart failure.
    Kostis JB; Klapholz M; Delaney C; Vesterqvist O; Cohen M; Manning JA; Jemal M; Kollia GD; Liao WC
    J Clin Pharmacol; 2001 Dec; 41(12):1280-90. PubMed ID: 11762555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of midazolam in patients with congestive heart failure.
    Patel IH; Soni PP; Fukuda EK; Smith DF; Leier CV; Boudoulas H
    Br J Clin Pharmacol; 1990 May; 29(5):565-9. PubMed ID: 2350533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosis.
    Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE
    Biopharm Drug Dispos; 2013 Sep; 34(6):336-47. PubMed ID: 23794414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cibenzoline in patients with renal impairment.
    Canal M; Flouvat B; Aubert P; Guedon J; Prinseau J; Baglin A
    J Clin Pharmacol; 1985 Apr; 25(3):197-203. PubMed ID: 3998200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure.
    Põder P; Eha J; Sundberg S; Antila S; Heinpalu M; Loogna I; Planken U; Rantanen S; Lehtonen L
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):365-73. PubMed ID: 12940594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure.
    Cook JA; Smith DE; Cornish LA; Tankanow RM; Nicklas JM; Hyneck ML
    Clin Pharmacol Ther; 1988 Nov; 44(5):487-500. PubMed ID: 3180632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure elevates serum levels of cibenzoline in arrhythmic patients.
    Kotake T; Takada M; Komamura K; Kamakura S; Miyatake K; Kitakaze M; Morishita H
    Circ J; 2006 May; 70(5):588-92. PubMed ID: 16636495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.
    Canal M; Flouvat B; Tremblay D; Dufour A
    Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.